Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

The problem with COPD is you have obstruction ... improve patients' breathing and decreases the exacerbations. And there are a host of medications we can use now that barely existed or didn ...

Treatment for asthma and COPD exacerbations have not changed in 50 years despite causing 3.8 million deaths worldwide a year combined. "Benralizumab is a safe and effective drug already used to ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Knowledge of these risks would inform rational drug prescribing for prevention of cardiovascular disease, not only at exacerbation but also in stable COPD.

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

The drug provides both bronchodilation ... could also be heading for approval in COPD – at the second attempt – after reducing exacerbations in the phase 3 MATINEE trial, while Amgen and ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

The following is a summary of “Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe ...